Method and apparatus for monitoring alteration of flow characteristics in a liquid sample

• US 20110083974A1
• Filed: 11/16/2010
• Published: 04/14/2011
• Est. Priority Date: 04/07/2006
• Status: Active Grant

• Current Assignee: Agamatrix Incorporated (AgaMatrix Holdings LLC d/b/a WaveForm Diabetes)
• Original Assignee: Agamatrix Incorporated (AgaMatrix Holdings LLC d/b/a WaveForm Diabetes)
• Inventors: Nguyen, Ha, Harding, Ian, Williams, Richard, Iyengar, Sridhar G.
• Granted Patent: US 8,623,280 B2
• Time in Patent Office: Days
• US Class Current: 205/792
• CPC Class Codes: G01N 27/26 by investigating electrochemical variables; by using electrolysis or electrophoresis
• CPC Class Codes: G01N 33/4905 Determining clotting time of blood by chemical methods G01N33/86, C12Q1/56
• CPC Class Codes: G01N 33/86 involving blood coagulating time or factors, or their receptors

Abstract

A device for measuring blood coagulation time is formed from a first substrate; a second substrate; a spacer layer disposed between the first and second substrates, said spacer layer having an opening formed therein defining a sample receiving chamber, a vented sink chamber, and an elongated reservoir forming a conduit for liquid movement between the sample receiving chamber and the sink chamber; a first electrode disposed on the first substrate, said first electrode being exposed in the reservoir portion through a first opening in the spacer layer; and a second electrode disposed on the second substrate, said second electrode being exposed in the reservoir portion through a second opening in the spacer layer. The device of the invention is used in combination with an apparatus that is connected to the first and second electrodes for measuring current flow between the first and second electrodes. Changes in observed current are indicative of flow through the device, and a cessation of flow indicates coagulation.

Claims

1-27. -27. (canceled)

28. A device for measuring blood coagulation time, comprising:

(a) a first substrate;

(b) a second substrate;

(c) a spacer layer disposed between the first and second substrates, said spacer layer having an opening formed therein defining a sample receiving chamber, a vented sink chamber, and an elongated reservoir forming a conduit for liquid movement between the sample receiving chamber and the sink chamber;

(d) a first electrode disposed on the first substrate, said first electrode being exposed through the reservoir portion of the opening in the spacer layer; and

(e) a second electrode disposed on the second substrate, said second electrode being exposed through the reservoir portion of the opening in the spacer layer;

wherein the first and second electrodes are in electrically conductive contact with the elongated reservoir such that an electrical signal can be detected between the first and second electrodes when a conductive liquid sample is disposed in the reservoir and at least one of the electrodes is electrically insulated from the sample receiving chamber and from the sink chamber, wherein the relative sizes of the reservoir, the sink, and a region at the connection of the reservoir and the sink are such that the time required for emptying sample from the reservoir into the sink to occur in the absence of coagulation is greater than the time required for coagulation to occur; and

(f) first and second contact leads extending from the first and second electrodes, respectively, for connection of the device to an apparatus for measuring an electrochemical signal between the first and second electrodes through a sample in the reservoir.

29. The device of claim 28, further comprising a reagent effective to promote coagulation of blood that is indicative of the clotting ability of the blood, said reagent disposed to contact a blood sample introduced to the sample receiving chamber.

30. The device of claim 29, wherein the reagent is thromboplastin.

31. The device of claim 28, wherein the first and second electrodes are formed from gold.

32. The device of claim 28, wherein the reservoir has a narrowed portion separating a main portion of the reservoir from the sink.

33. The device of claim 28, further comprising a wetting agent effective to promote flow of blood from the sample receiving chamber through the reservoir to the sink chamber.

34. The device of claim 33, wherein the wetting agent is an ocytlphenol ethoxylate or p-nonyl phenoxypolyglycidol.

35. The device of claim 28, wherein the sample receiving chamber, reservoir and sink chamber each have a width dimension and a smaller depth dimension, and wherein the depth dimension of the sink chamber is less than the depth dimension of the reservoir.

36. The device of claim 35, further comprising a reagent effective to promote coagulation of blood disposed to contact a blood sample introduced to the sample receiving chamber.

37. The device of claim 36, wherein the reagent is thromboplastin.

38. The device of claim 35, wherein the first and second electrodes are formed from gold.

39. The device of claim 35, wherein the reservoir has a narrowed portion separating a main portion of the reservoir from the sink.

40. The device of claim 35, further comprising a wetting agent effective to promote flow of blood from the sample receiving chamber through the reservoir to the sink chamber.

41. The device of claim 40, wherein the wetting agent is an ocytlphenol ethoxylate or p-nonyl phenoxypolyglycidol.

42. The device of claim 28, wherein the elongated reservoir has a cross-sectional area in a plane extending perpendicular to a line extending along the elongated reservoir from the sample receiving chamber to the sink chamber, and the cross-sectional area of the elongated reservoir is smaller than parallel cross-sectional areas of the sample receiving chamber and the sink chamber

43. The device of claim 28, further comprising a second reagent effective to promote more rapid coagulation of blood if a target analyte material is present in the blood sample, said second reagent being disposed to contact a blood sample introduced to the sample receiving chamber.

44. The device of claim 28, wherein second reagent and the target analyte material are members of an antibody/antigen pair.

45. A method for determining coagulation time of a blood sample, comprising the steps of:

(a) introducing a blood sample into a device for measuring blood coagulation time wherein the sample is combined with a reagent effective to promote coagulation of blood disposed to contact a blood sample introduced to the sample receiving chamber in the device, said device comprising;

a first substrate;

a second substrate;

a spacer layer disposed between the first and second substrates, said spacer layer having an opening formed therein defining a sample receiving chamber, a vented sink chamber, and an elongated reservoir forming a conduit for liquid movement between the sample receiving chamber and the sink chamber;

a first electrode disposed on the first substrate, said first electrode being exposed through the reservoir portion of the opening in the spacer layer; and

a second electrode disposed on the second substrate, said second electrode being exposed through the reservoir portion of the opening in the spacer layer,

wherein the first and second electrodes are in electrically conductive contact with the elongated reservoir such that an electrical signal can be detected between the first and second electrodes when a conductive liquid sample is disposed in the reservoir and at least one of the electrodes is electrically insulated from the sample receiving chamber and from the sink chamber, wherein the relative sizes of the reservoir, the sink, and a region at the connection of the reservoir and the sink are such that the time required for emptying sample from the reservoir into the sink to occur in the absence of coagulation is greater than the time required for coagulation to occur,

(b) measuring current between the first and second electrodes, and

(c) determining from the change in measured current a coagulation time.

46. The method of claim 45, wherein the coagulation time is determined from the rate of decay of the current.

47. The method of claim 46, wherein the coagulation time is determined from extrapolation of the initial slope of current as a function of time to a current of zero.

48. The method of claim 46, wherein the coagulation time is determined from extrapolation of the initial slope of current as a function of time to a predetermined low current value.

49. The method of claim 48, wherein the predetermined low current value is average value of measured plateau currents for the device.

50. The method of claim 45, wherein the determination of coagulation time is made by detection of changes in slope of current as a function of time when the phase transition from flowing to coagulated occurs.

51. The method of claim 45, wherein the coagulation time is the time at which the initial slope of current as a function of time intersects the slope of the plateau current.

52. A combination comprising

(a) a device for measuring blood coagulation time, comprising:

a first substrate;

a second substrate;

a spacer layer disposed between the first and second substrates, said spacer layer having an opening formed therein defining a sample receiving chamber, a vented sink chamber, and an elongated reservoir forming a conduit for liquid movement between the sample receiving chamber and the sink chamber;

a first electrode disposed on the first substrate, said first electrode being exposed through the reservoir portion of the opening in the spacer layer; and

a second electrode disposed on the second substrate, said second electrode being exposed through the reservoir portion of the opening in the spacer layer,

wherein the first and second electrodes are in electrically conductive contact with the elongated reservoir such that an electrical signal can be detected between the first and second electrodes when a conductive liquid sample is disposed in the reservoir and at least one of the electrodes is electrically insulated from the sample receiving chamber and from the sink chamber, wherein the relative sizes of the reservoir, the sink, and a region at the connection of the reservoir and the sink are such that the time required for emptying sample from the reservoir into the sink to occur in the absence of coagulation is greater than the time required for coagulation to occur; and

first and second contact leads extending from the first and second electrodes, respectively, for connection of the device to an apparatus for measuring an electrochemical signal between the first and second electrodes through a sample in the reservoir; and

(b) an apparatus connected to the first and second electrodes for measuring current flow between the first and second electrodes, said apparatus comprising connectors configured to connect to the first and second contact leads, a signal processor for converting a current signal to an indication of coagulation time, and means for communicating the indication of coagulation time to a user.